212 related articles for article (PubMed ID: 21666675)
1. Recognition of the F&H motif by the Lowe syndrome protein OCRL.
Pirruccello M; Swan LE; Folta-Stogniew E; De Camilli P
Nat Struct Mol Biol; 2011 Jun; 18(7):789-95. PubMed ID: 21666675
[TBL] [Abstract][Full Text] [Related]
2. Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.
Swan LE; Tomasini L; Pirruccello M; Lunardi J; De Camilli P
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3511-6. PubMed ID: 20133602
[TBL] [Abstract][Full Text] [Related]
3. All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding.
McCrea HJ; Paradise S; Tomasini L; Addis M; Melis MA; De Matteis MA; De Camilli P
Biochem Biophys Res Commun; 2008 May; 369(2):493-9. PubMed ID: 18307981
[TBL] [Abstract][Full Text] [Related]
4. Lowe syndrome-linked endocytic adaptors direct membrane cycling kinetics with OCRL in
Luscher A; Fröhlich F; Barisch C; Littlewood C; Metcalfe J; Leuba F; Palma A; Pirruccello M; Cesareni G; Stagi M; Walther TC; Soldati T; De Camilli P; Swan LE
Mol Biol Cell; 2019 Aug; 30(17):2268-2282. PubMed ID: 31216233
[TBL] [Abstract][Full Text] [Related]
5. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.
Erdmann KS; Mao Y; McCrea HJ; Zoncu R; Lee S; Paradise S; Modregger J; Biemesderfer D; Toomre D; De Camilli P
Dev Cell; 2007 Sep; 13(3):377-90. PubMed ID: 17765681
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Effect of Lowe Syndrome-Causing Mutation p.Asn591Lys of OCRL-1 through Protein-Protein Interaction Networks and Molecular Dynamics Simulations.
Acosta-Tapia N; Galindo JF; Baldiris R
J Chem Inf Model; 2020 Feb; 60(2):1019-1027. PubMed ID: 31967472
[TBL] [Abstract][Full Text] [Related]
7. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature:
Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992
[TBL] [Abstract][Full Text] [Related]
8. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
9. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
[TBL] [Abstract][Full Text] [Related]
10. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.
Pirruccello M; De Camilli P
Trends Biochem Sci; 2012 Apr; 37(4):134-43. PubMed ID: 22381590
[TBL] [Abstract][Full Text] [Related]
11. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
[TBL] [Abstract][Full Text] [Related]
12. A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.
Mao Y; Balkin DM; Zoncu R; Erdmann KS; Tomasini L; Hu F; Jin MM; Hodsdon ME; De Camilli P
EMBO J; 2009 Jul; 28(13):1831-42. PubMed ID: 19536138
[TBL] [Abstract][Full Text] [Related]
13. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
Shi RM; Bian XH; Li LM; Liu XH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
Lin T; Orrison BM; Leahey AM; Suchy SF; Bernard DJ; Lewis RA; Nussbaum RL
Am J Hum Genet; 1997 Jun; 60(6):1384-8. PubMed ID: 9199559
[TBL] [Abstract][Full Text] [Related]
15. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
Zhang X; Jefferson AB; Auethavekiat V; Majerus PW
Proc Natl Acad Sci U S A; 1995 May; 92(11):4853-6. PubMed ID: 7761412
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.
Hou X; Hagemann N; Schoebel S; Blankenfeldt W; Goody RS; Erdmann KS; Itzen A
EMBO J; 2011 Apr; 30(8):1659-70. PubMed ID: 21378754
[TBL] [Abstract][Full Text] [Related]
17. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
[TBL] [Abstract][Full Text] [Related]
19. [Oculo-cerebro-renal Lowe syndrome: clinical, biochemical and molecular studies in a Moroccan patient].
Chabaâ L; Monnier N; Dahri S; Jorio M; Lunardi J; Chabraoui L
Ann Biol Clin (Paris); 2006; 64(1):53-9. PubMed ID: 16420990
[TBL] [Abstract][Full Text] [Related]
20. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.
Wu G; Zhang W; Na T; Jing H; Wu H; Peng JB
Am J Physiol Cell Physiol; 2012 May; 302(10):C1479-91. PubMed ID: 22378746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
